About AQUILUS PHARMACEUTICALS, INC.
Aquilus Pharmaceuticals is a Pre-series A biotech company focused on developing a first-in-class medication for neurodegenerative diseases, particularly Amyotrophic Lateral Sclerosis (ALS), with funding from the ALS Association, NIH, and Department of Defense grants.
Development of a small molecule MMP inhibitor (AQU-118) for neurodegenerative diseasesConducting IND enabling studies and planning for Phase I clinical trialsResearch in neurotherapeutics with a focus on ALS treatmentCollaboration with academic and clinical experts in neurology and ALS research
Is this your company?
Claim AQUILUS PHARMACEUTICALS, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim AQUILUS PHARMACEUTICALS, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.